Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Post by mcarter4on Sep 26, 2003 8:53am
259 Views
Post# 6462554

The "Take it or Leave it PP"

The "Take it or Leave it PP"I believe fotw or someone else recently posted that ONC was approached by CC and were told the money was available for that day only. CC also indicated that the money for bio was drying up. Unfortunately, it sounds to me like ONC blinked, pure and simple. If true this is a bad statement re. mngt, to be played like a cheap piano by some two bit CDN firm. There huge dollars available, pension funds and other big dollar players are moving out of bonds looking for good investments. If the science is sound futre funding will not be a problem. How seasoned is the mngt team of ONC in the world of big corporate finance, this may be the weak link (they need better connections in the US). Interestingly CC played their card right before US exposure, why most likely to head off ONC from real money and real money managers.
Bullboard Posts